169 related articles for article (PubMed ID: 6086978)
1. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
[TBL] [Abstract][Full Text] [Related]
2. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
Miyake S
Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231
[TBL] [Abstract][Full Text] [Related]
4. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
[TBL] [Abstract][Full Text] [Related]
6. [Serum alpha-1-fetoprotein and serum lactic dehydrogenase isoenzymes in liver tumours (author's transl)].
Polterauer P; Rauhs R; Puxkandl H
Wien Klin Wochenschr; 1981 Apr; 93(7):227-30. PubMed ID: 6167076
[TBL] [Abstract][Full Text] [Related]
7. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
8. Hepatic transaminase activity in alocholic liver disease.
Matloff DS; Selinger MJ; Kaplan MM
Gastroenterology; 1980 Jun; 78(6):1389-92. PubMed ID: 7372058
[TBL] [Abstract][Full Text] [Related]
9. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of human serum and liver tissue immunoreactive gamma-glutamyl transpeptidase in patients with various liver diseases].
Yamada M
Hokkaido Igaku Zasshi; 1988 Jan; 63(1):44-55. PubMed ID: 2896151
[TBL] [Abstract][Full Text] [Related]
11. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
12. [The diagnostic value of glutamic acid dehydrogenase].
Rettenbacher-Däubner H; Rieder H; Sburny I
Acta Hepatosplenol; 1967; 14(4):209-21. PubMed ID: 4297959
[No Abstract] [Full Text] [Related]
13. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
14. [GOT and GPT: interpretation of the test results].
Suzuki H; Endo Y
Nihon Rinsho; 1969 Mar; ():1027-34. PubMed ID: 5408750
[No Abstract] [Full Text] [Related]
15. Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases.
Asaka M; Nagase K; Miyazaki T; Alpert E
Gastroenterology; 1983 Jan; 84(1):155-60. PubMed ID: 6183164
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of serum procollagen-III-peptide in patients with solid tumor].
Takahashi T; Takami H; Abe O; Ootake T; Kano S
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1480-6. PubMed ID: 6204598
[TBL] [Abstract][Full Text] [Related]
17. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
Bolarin D; Andy JJ; Alabi ZO
Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
[TBL] [Abstract][Full Text] [Related]
18. The relationship between hepatitis-associated antigen and the development of hepatocellular cancer.
Theodoropoulos G; Economopoulos P; Mitakos S; Angelopoulos Ba
Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):430-2. PubMed ID: 4377058
[No Abstract] [Full Text] [Related]
19. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver.
Raedsch R; Stiehl A; Sieg A; Walker S; Kommerell B
Gastroenterology; 1983 Dec; 85(6):1265-70. PubMed ID: 6628925
[TBL] [Abstract][Full Text] [Related]
20. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
